adenosine 5'-o-(1-thiodiphosphate) has been researched along with ouabain in 1 studies
Studies (adenosine 5'-o-(1-thiodiphosphate)) | Trials (adenosine 5'-o-(1-thiodiphosphate)) | Recent Studies (post-2010) (adenosine 5'-o-(1-thiodiphosphate)) | Studies (ouabain) | Trials (ouabain) | Recent Studies (post-2010) (ouabain) |
---|---|---|---|---|---|
23 | 0 | 3 | 16,357 | 72 | 747 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blayac, JP; Chapal, J; Hillaire-Buys, D; Linck, N; Loubatières-Mariani, MM; Petit, P | 1 |
1 other study(ies) available for adenosine 5'-o-(1-thiodiphosphate) and ouabain
Article | Year |
---|---|
Involvement of K+ channel permeability changes in the L-NAME and indomethacin resistant part of adenosine-5'-O-(2-thiodiphosphate)-induced relaxation of pancreatic vascular bed.
Topics: Adenosine Diphosphate; Animals; Apamin; Blood Vessels; Charybdotoxin; Enzyme Inhibitors; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Ouabain; Pancreas; Potassium; Potassium Channels; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Thionucleotides; Tolbutamide; Vasoconstrictor Agents; Vasodilator Agents | 1998 |